Treatment of PDX-derived neuroblastoma organoids disrupted the 3D structure, decreased cell viability, increased cell death, induced cell cycle arrest, and downregulated mediators of the RAS and AKT signaling pathway. The gene discussed is AKT1; the disease is neuroblastoma.